Limandri Barbara J
J Psychosoc Nurs Ment Health Serv. 2018 Apr 1;56(4):8-11. doi: 10.3928/02793695-20180319-01.
Treating individuals with borderline personality disorder (BPD) is a complex and challenging process fraught with clinician stigma and bias. Clinically, polypharmacy is the most common approach, even though it is more likely to produce greater drug-drug adverse effects and interactions than effective improvement in symptoms. Currently, there are no approved medications specific for the treatment of BPD. The current article reviews the extant literature on psychopharmacology and provides treatment recommendations. [Journal of Psychosocial Nursing and Mental Health Services, 56(4), 8-11.].
治疗边缘型人格障碍（BPD）患者是一个复杂且具有挑战性的过程，充满了临床医生的污名化和偏见。临床上，联合用药是最常见的方法，尽管它比有效改善症状更有可能产生更大的药物不良反应和相互作用。目前，尚无专门批准用于治疗BPD的药物。本文回顾了关于精神药理学的现有文献并提供了治疗建议。[《心理社会护理与精神卫生服务杂志》，56(4)，8 - 11。]
